WO2001045835A1 - Sensitive substance encapsulation - Google Patents

Sensitive substance encapsulation Download PDF

Info

Publication number
WO2001045835A1
WO2001045835A1 PCT/US2000/033673 US0033673W WO0145835A1 WO 2001045835 A1 WO2001045835 A1 WO 2001045835A1 US 0033673 W US0033673 W US 0033673W WO 0145835 A1 WO0145835 A1 WO 0145835A1
Authority
WO
WIPO (PCT)
Prior art keywords
sensitive material
solid carrier
atmosphere inert
encapsulating
encapsulant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/033673
Other languages
English (en)
French (fr)
Inventor
Carl J. Pacifico
Wen-Hsin Wu
Marta Fraley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Balchem Corp
Original Assignee
Balchem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Balchem Corp filed Critical Balchem Corp
Priority to EP00984255A priority Critical patent/EP1242174A1/en
Priority to NZ519521A priority patent/NZ519521A/en
Priority to AU20908/01A priority patent/AU780513C/en
Priority to KR1020027007918A priority patent/KR20020095172A/ko
Priority to MXPA02006202A priority patent/MXPA02006202A/es
Priority to JP2001546771A priority patent/JP2003517831A/ja
Priority to BR0016577-8A priority patent/BR0016577A/pt
Priority to CA002394520A priority patent/CA2394520A1/en
Publication of WO2001045835A1 publication Critical patent/WO2001045835A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
    • A23L27/12—Natural spices, flavouring agents or condiments; Extracts thereof from fruit, e.g. essential oils
    • A23L27/13—Natural spices, flavouring agents or condiments; Extracts thereof from fruit, e.g. essential oils from citrus fruits
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72—Encapsulation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/75—Fixation, conservation, or encapsulation of flavouring agents the flavouring agents being bound to a host by chemical, electrical or like forces, e.g. use of precursors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/77—Use of inorganic solid carriers, e.g. silica
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Fats And Perfumes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Seasonings (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Glanulating (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Lubricants (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
PCT/US2000/033673 1999-12-22 2000-12-13 Sensitive substance encapsulation Ceased WO2001045835A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP00984255A EP1242174A1 (en) 1999-12-22 2000-12-13 Sensitive substance encapsulation
NZ519521A NZ519521A (en) 1999-12-22 2000-12-13 Sensitive substance encapsulation
AU20908/01A AU780513C (en) 1999-12-22 2000-12-13 Sensitive substance encapsulation
KR1020027007918A KR20020095172A (ko) 1999-12-22 2000-12-13 민감성 물질의 캡슐화
MXPA02006202A MXPA02006202A (es) 1999-12-22 2000-12-13 Encapsulacion de sustancia sensible.
JP2001546771A JP2003517831A (ja) 1999-12-22 2000-12-13 感受性物質のカプセル化
BR0016577-8A BR0016577A (pt) 1999-12-22 2000-12-13 Método para encapsular um material sensìvel
CA002394520A CA2394520A1 (en) 1999-12-22 2000-12-13 Sensitive substance encapsulation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/469,368 US6251478B1 (en) 1999-12-22 1999-12-22 Sensitive substance encapsulation
US09/469,368 1999-12-22

Publications (1)

Publication Number Publication Date
WO2001045835A1 true WO2001045835A1 (en) 2001-06-28

Family

ID=23863520

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/033673 Ceased WO2001045835A1 (en) 1999-12-22 2000-12-13 Sensitive substance encapsulation

Country Status (10)

Country Link
US (2) US6251478B1 (https=)
EP (2) EP1433525A1 (https=)
JP (1) JP2003517831A (https=)
KR (1) KR20020095172A (https=)
CN (1) CN1413125A (https=)
AU (1) AU780513C (https=)
CA (1) CA2394520A1 (https=)
MX (1) MXPA02006202A (https=)
NZ (1) NZ519521A (https=)
WO (1) WO2001045835A1 (https=)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004034791A1 (en) * 2002-10-21 2004-04-29 Givaudan Sa Pesticidal compositions
US8921054B2 (en) 2000-11-16 2014-12-30 Curemark, Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US8980252B2 (en) 2011-04-21 2015-03-17 Curemark Llc Methods of treatment of schizophrenia
US9017665B2 (en) 2008-04-18 2015-04-28 Curemark, Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US9023344B2 (en) 2008-03-13 2015-05-05 Curemark, Llc Method of treating toxemia
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9061033B2 (en) 2008-10-03 2015-06-23 Curemark Llc Methods and compositions for the treatment of symptoms of prion diseases
US9084784B2 (en) 2009-01-06 2015-07-21 Curelon Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
US9107419B2 (en) 2009-01-06 2015-08-18 Curelon Llc Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces
US9233146B2 (en) 2000-08-14 2016-01-12 Curemark, Llc Method of treating and diagnosing Parkinson's disease and related dysautonomic disorders
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US9345721B2 (en) 2005-08-30 2016-05-24 Curemark, Llc Use of lactulose in the treatment of autism
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
US9624525B2 (en) 1999-12-17 2017-04-18 Curemark, Llc Method for treating pervasive development disorders
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US11016104B2 (en) 2008-07-01 2021-05-25 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
US12226464B2 (en) 2017-04-10 2025-02-18 Curemark, Llc Compositions for treating addiction

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001255431B2 (en) * 2000-04-18 2007-01-04 Natural As Conjugated linoleic acid powder
US20030149288A1 (en) * 2000-04-18 2003-08-07 Natural Asa Conjugated linoleic acid powder
US7070820B2 (en) * 2000-10-02 2006-07-04 Novozymes A/S Coated particles containing an active
ES2187380A1 (es) * 2001-11-16 2003-06-01 Sanchez Juan Balufo Mejoras introducidas en productos destinados al consumo humano o animal.
US20030175382A1 (en) * 2002-03-14 2003-09-18 Dally Vernetta L. Heat released encapsulated yeast
ES2268432T3 (es) 2002-07-23 2007-03-16 Wm. Wrigley Jr. Company Sabores encapsulados y goma de mascar que emplea los mismos.
US6835397B2 (en) 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
WO2004076657A2 (en) 2003-02-28 2004-09-10 Mcgill University Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
EP1462013A1 (de) * 2003-03-27 2004-09-29 Cognis Iberia, S.L. Mikrokapseln, bestehend aus einer Hüllmembran und einer Hydroxytyrosol enthaltenden Matrix
US7615245B2 (en) 2003-04-11 2009-11-10 Cargill, Incorporated Pellet systems for preparing beverages
EP1662912B1 (en) * 2003-05-12 2016-12-21 Grand Brands Llc An edible mix and method of making the same
ES2221804B1 (es) * 2003-06-18 2006-04-01 Lipofoods, S.L. Microcapsulas para la administracion de ingredientes activos.
US20050181019A1 (en) * 2003-07-03 2005-08-18 Slim-Fast Foods Company, Division Of Conopco, Inc. Nutrition bar
KR101176660B1 (ko) 2003-08-11 2012-08-23 오라제닉스, 인코포레이티드 구강 건강의 유지를 위한 조성물 및 방법
CN1302112C (zh) * 2003-09-17 2007-02-28 广东肇庆星湖生物科技股份有限公司 利用毕赤酵母生产高比活耐高温植酸酶
JP2007529214A (ja) * 2004-03-19 2007-10-25 ダニスコ エイ／エス ショートニング用乳化剤組成物
CN1956733B (zh) * 2004-04-07 2012-10-10 白藜芦醇合伙人有限责任公司 营养补充剂及其加工方法
US20050271609A1 (en) * 2004-06-08 2005-12-08 Colgate-Palmolive Company Water-based gelling agent spray-gel and its application in personal care formulation
EP1627573A1 (en) * 2004-08-20 2006-02-22 Firmenich Sa A process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
US20060115553A1 (en) * 2004-12-01 2006-06-01 Slim-Fast Foods Company, Division Of Conopco, Inc. Nutrition bar or other food product and process of making
US20060228448A1 (en) * 2005-04-11 2006-10-12 The Iams Company Pet food compositions comprising two components
US7700142B2 (en) * 2005-05-16 2010-04-20 Diane Wright Hoffpauer Fortified cereal bran to promote digestive health
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
US20080160151A1 (en) * 2006-12-29 2008-07-03 Bary Lyn Zeller Method for Preparing Beverage Compositions Having Improved Aroma Release Characteristics and Compositions for Use Therein
US8424541B2 (en) 2007-07-16 2013-04-23 Philip Morris Usa Inc. Tobacco-free oral flavor delivery pouch product
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
KR101510308B1 (ko) * 2008-09-08 2015-04-08 주식회사 엘지생활건강 트랜스글루타미나제 및 천초목 추출물을 함유하는 손상 모발 회복 조성물
FR2936131B1 (fr) * 2008-09-24 2011-01-14 Bongrain Sa Procede et installation de preparation d'un fromage ou d'une specialite fromagere, et produits obtenus
JP4948500B2 (ja) * 2008-10-03 2012-06-06 モハン シャラッド 固形石鹸及びこれを用いた送達方法
IT1400821B1 (it) * 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico
BRPI1010548A2 (pt) 2009-05-11 2016-03-15 Us Smokeless Tobacco Co compósito flavorizante encapsulado, compósito de adoçante artificial encapsulado e produto.
IT1401460B1 (it) * 2010-06-11 2013-07-26 Probiotical Spa "ceppi di batteri probiotici produttori di vitamina b12"
JP2012055288A (ja) * 2010-09-13 2012-03-22 Kaneka Corp 安定化された生菌製剤およびその製造方法。
US20140147500A1 (en) 2010-11-19 2014-05-29 Joan M. Fallon Preparation and Use of Combination Enzyme and Gastrointestinal Modulator Delivery Systems
WO2013074948A1 (en) 2011-11-16 2013-05-23 Resveratrol Partners, Llc Compositions containing resveratrol and nucleotides
JP6796372B2 (ja) 2012-01-03 2020-12-09 キュアマーク， リミテッド ライアビリティ カンパニー 神経障害および精神障害の行動症状を治療する方法
AU2013226402B2 (en) 2012-02-27 2017-05-18 Oragenics, Inc. Variants of the lantibiotic MU1140 and other lantibiotics with improved pharmacological properties and structural features
WO2013192413A1 (en) 2012-06-20 2013-12-27 Mishra Munmaya K Smokeless tobacco comprising lipid granules
MX2016011998A (es) 2014-03-20 2016-12-05 Ultradent Products Inc Sistemas de empaquetado que incluyen composicion sacrificatoria.
KR101804284B1 (ko) * 2015-09-24 2017-12-14 학교법인연세대학교 프로바이오틱 유산균을 함유하는 우유과자의 제조방법
CA3236269A1 (en) * 2021-10-29 2023-05-04 Corn Products Development, Inc. Method for obtaining a gelled plant protein composition using transglutaminase

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB825480A (en) * 1957-07-13 1959-12-16 Johann Carl Pflueger Improvements in or relating to ingestible dry micro-organism preparations and method for producing the same
GB1318799A (en) * 1969-10-22 1973-05-31 Balchem Corp Encapsulation process
JPS5526807A (en) * 1978-08-14 1980-02-26 Norio Tanaka Powdery perfume
WO1996009773A1 (en) * 1994-09-29 1996-04-04 Mccormick & Company, Inc. Flavor encapsulation

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857964A (en) 1973-02-09 1974-12-31 Brook D Controlled release flavor compositions
JPS5231981A (en) * 1975-08-18 1977-03-10 Takeda Chem Ind Ltd Microcapsule preparation method
US4232047A (en) * 1978-05-30 1980-11-04 Griffith Laboratories U.S.A., Inc. Food supplement concentrate in a dense glasseous extrudate
US4576826A (en) 1980-11-03 1986-03-18 Nestec S. A. Process for the preparation of flavorant capsules
PH18554A (en) 1981-07-21 1985-08-09 Unilever Nv Encapsulation of volatile liquids
US4532145A (en) 1983-12-19 1985-07-30 General Foods Corporation Fixing volatiles in an amorphous substrate and products therefrom
US4689235A (en) * 1984-01-31 1987-08-25 Scm Corporation Encapsulation matrix composition and encapsulate containing same
US4828857A (en) 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US5004595A (en) 1986-12-23 1991-04-02 Warner-Lambert Company Multiple encapsulated flavor delivery system and method of preparation
US5009900A (en) * 1989-10-02 1991-04-23 Nabisco Brands, Inc. Glassy matrices containing volatile and/or labile components, and processes for preparation and use thereof
US5209879A (en) 1990-04-06 1993-05-11 Redding Bruce K Method for inducing transformations in waxes
WO1993018667A1 (en) 1992-03-20 1993-09-30 Church & Dwight Company, Inc. Encapsulated dietary fatty acid salt products
US5601865A (en) 1992-09-22 1997-02-11 Mccormick & Company, Inc. Flavor encapsulation
US5792505A (en) 1992-09-22 1998-08-11 Mccormick & Company, Inc. Flavor encapsulation
US5607708A (en) 1992-12-14 1997-03-04 Hunt-Wesson, Inc. Encapsulated volatile flavoring materials
EP0693884A4 (en) 1993-04-16 1996-03-27 Mccormick & Co Inc ENCLOSURE COMPOSITIONS
CH687053A5 (fr) 1993-10-05 1996-09-13 Crina Additifs pour l'alimentation animale et procédé pour leur préparation.
US5506353A (en) 1994-03-21 1996-04-09 Firmenich Sa Particulate hydrogenated starch hydrolysate based flavoring materials and use of same
US5399368A (en) 1994-09-06 1995-03-21 Nestec S.A. Encapsulation of volatile aroma compounds
DE4432905C2 (de) 1994-09-15 1996-07-18 Immuno Gmbh Verfahren zur Bestimmung von freiem Apoprotein (a)
US5580593A (en) 1995-02-01 1996-12-03 Nestec S.A. Process for making encapsulated sensory agents
US5496574A (en) 1995-02-01 1996-03-05 Nestec S.A. Encapsulated sensory agents
US5736178A (en) 1995-05-02 1998-04-07 Opta Food Ingredients, Inc. Colloidal dispersions of gluten, method of making and use therefor
US5756136A (en) 1995-06-02 1998-05-26 Mccormick & Company, Inc. Controlled release encapsulation compositions
FR2750997B1 (fr) * 1996-07-12 2003-04-25 Rhone Poulenc Chimie Granules d'un produit parfume a liberation controlee, leur procede d'obtention et leur utilisation dans les compositions detergentes pour lave-vaisselle
US6500463B1 (en) * 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB825480A (en) * 1957-07-13 1959-12-16 Johann Carl Pflueger Improvements in or relating to ingestible dry micro-organism preparations and method for producing the same
GB1318799A (en) * 1969-10-22 1973-05-31 Balchem Corp Encapsulation process
JPS5526807A (en) * 1978-08-14 1980-02-26 Norio Tanaka Powdery perfume
WO1996009773A1 (en) * 1994-09-29 1996-04-04 Mccormick & Company, Inc. Flavor encapsulation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 004, no. 054 (C - 008) 23 April 1980 (1980-04-23) *
See also references of EP1242174A1 *

Cited By (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9624526B2 (en) 1999-12-17 2017-04-18 Curemark Llc Method for treating pervasive development disorders
US9624525B2 (en) 1999-12-17 2017-04-18 Curemark, Llc Method for treating pervasive development disorders
US9233146B2 (en) 2000-08-14 2016-01-12 Curemark, Llc Method of treating and diagnosing Parkinson's disease and related dysautonomic disorders
US8921054B2 (en) 2000-11-16 2014-12-30 Curemark, Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US10209253B2 (en) 2000-11-16 2019-02-19 Curemark, Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US9377459B2 (en) 2000-11-16 2016-06-28 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
WO2004034791A1 (en) * 2002-10-21 2004-04-29 Givaudan Sa Pesticidal compositions
US9345721B2 (en) 2005-08-30 2016-05-24 Curemark, Llc Use of lactulose in the treatment of autism
US11033563B2 (en) 2005-08-30 2021-06-15 Curemark, Llc Use of lactulose in the treatment of autism
US10350229B2 (en) 2005-08-30 2019-07-16 Curemark, Llc Use of lactulose in the treatment of autism
US9925250B2 (en) 2008-03-13 2018-03-27 Curemark, Llc Method of treating proteinuria in pregnancy
US9408895B2 (en) 2008-03-13 2016-08-09 Curemark, Llc Method of treating pregnancy-induced hypertension
US9023344B2 (en) 2008-03-13 2015-05-05 Curemark, Llc Method of treating toxemia
US11045527B2 (en) 2008-03-13 2021-06-29 Curemark, Llc Method of diagnosing preeclampsia or pregnancy-induced hypertension
US9017665B2 (en) 2008-04-18 2015-04-28 Curemark, Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US11235038B2 (en) 2008-04-18 2022-02-01 Curemark, Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US10272141B2 (en) 2008-04-18 2019-04-30 Curemark, Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US9687534B2 (en) 2008-04-18 2017-06-27 Curemark, Llc Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
US10588948B2 (en) 2008-06-26 2020-03-17 Curemark, Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
US11016104B2 (en) 2008-07-01 2021-05-25 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US10413601B2 (en) 2008-10-03 2019-09-17 Curemark, Llc Methods and compositions for the treatment of symptoms of prion diseases
US9687535B2 (en) 2008-10-03 2017-06-27 Curemark, Llc Methods and compositions for the treatment of symptoms of prion diseases
US9061033B2 (en) 2008-10-03 2015-06-23 Curemark Llc Methods and compositions for the treatment of symptoms of prion diseases
US11357835B2 (en) 2009-01-06 2022-06-14 Galenagen, Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
US9895427B2 (en) 2009-01-06 2018-02-20 Galenagen, Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
US9084784B2 (en) 2009-01-06 2015-07-21 Curelon Llc Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces
US10736946B2 (en) 2009-01-06 2020-08-11 Galenagen, Llc Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces
US9107419B2 (en) 2009-01-06 2015-08-18 Curelon Llc Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces
US10098844B2 (en) 2009-04-13 2018-10-16 Curemark, Llc Enzyme delivery systems and methods of preparation and use
US9931302B2 (en) 2009-04-13 2018-04-03 Curemark , LLC Enzyme delivery systems and methods of preparation and use
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US11419821B2 (en) 2009-04-13 2022-08-23 Curemark, Llc Enzyme delivery systems and methods of preparation and use
US9415014B2 (en) 2009-04-13 2016-08-16 Curemark, Llc Enzyme delivery systems and methods of preparation and use
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
US10716835B2 (en) 2009-10-21 2020-07-21 Curemark, Llc Methods and compositions for the prevention and treatment of influenza
US10279016B2 (en) 2011-04-21 2019-05-07 Curemark, Llc Method of treatment of schizophreniform disorder
US8980252B2 (en) 2011-04-21 2015-03-17 Curemark Llc Methods of treatment of schizophrenia
US10940187B2 (en) 2011-04-21 2021-03-09 Curemark, Llc Method of treatment of schizophreniform disorder
US9492515B2 (en) 2011-04-21 2016-11-15 Curemark, Llc Method of treatment of schizophreniform disorder
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US11364287B2 (en) 2012-05-30 2022-06-21 Curemark, Llc Methods of treating celiac disease
US12226464B2 (en) 2017-04-10 2025-02-18 Curemark, Llc Compositions for treating addiction
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
US12485094B2 (en) 2020-09-10 2025-12-02 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Also Published As

Publication number Publication date
CA2394520A1 (en) 2001-06-28
EP1242174A1 (en) 2002-09-25
CN1413125A (zh) 2003-04-23
KR20020095172A (ko) 2002-12-20
AU2090801A (en) 2001-07-03
AU780513C (en) 2006-09-07
US6251478B1 (en) 2001-06-26
USRE40059E1 (en) 2008-02-12
NZ519521A (en) 2004-10-29
JP2003517831A (ja) 2003-06-03
AU780513B2 (en) 2005-03-24
MXPA02006202A (es) 2003-09-25
EP1433525A1 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
WO2001045835A1 (en) Sensitive substance encapsulation
US6991819B2 (en) Food product containing instable additives
EP0515403B1 (en) Stabilized cultures of microorganisms
ATE363248T1 (de) Chirurgisches implantat
CA2132737A1 (en) Hard Coated Gum with Improved Shelf Life
JPH02110900U (https=)
AU2001252663A1 (en) Spray-dried microbial cells
EP1314473A3 (en) Catalyst composition and process for the direct oxidation of propylene to propylene oxide
IL164949A0 (en) Method for producing a porous titanium material article
WO2001042163A3 (en) High-purity low-resistivity electrostatic chucks
Gherardini et al. Dissolution of outer wall of pollen grain during pollination
Kim et al. Active Oxidation of SiC in Low Dew-Point Hydrogen Above 1400 deg C
ATE335287T1 (de) Herstellungsverfahren für hochverdichtete supraleiter-massivkörper aus mgb2
BG60014B2 (bg) Метод за производство на композиционни керамични тела
GB1432101A (en) Ag-cdo-type electrical contact material
TWI265530B (en) Manufacturing method for oxide super conductivity wire
AU2003241672A1 (en) Method for preparing colloidal solution and carrier having colloidal particles fixed on surface thereof, fuel cell cathode, fuel cell anode and method for preparing the same and fuel cell using the same, and low temperature oxidation catalyst, method for preparing the same and fuel cell fuel modifying device using the same
JPS6230700A (ja) 化合物半導体単結晶およびその製造方法
CN113908850B (zh) 一种高效除乙烯催化模块及其制备方法与应用
JP4564384B2 (ja) 微生物膜の保存方法
WO2004061897A3 (en) Very low moisture o-ring and method for preparing the same
JPH0365125A (ja) キノコ用培養基並びに培地
JPS5355492A (en) Pellet-like catalyst
JPH0286770A (ja) 粉末ラクトバチルス・プランタラムの製法
CN1237479A (zh) 一种冰箱保鲜除味剂的制备方法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2394520

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 519521

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 20908/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020027007918

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 2001 546771

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/006202

Country of ref document: MX

Ref document number: 008175292

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2000984255

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000984255

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1020027007918

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: 2000984255

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000984255

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 519521

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 20908/01

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1020027007918

Country of ref document: KR